Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KH001 for Dentin Hypersensitivity
NCT06264453Phase 2Completed
- Sponsor
- HysensBio
- Start
- Mar 2024
- Primary completion
- Sep 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of selcopintide in dentin hypersensitivity (DH), sponsored by HysensBio. Started Mar 2024; status: completed.
02
Drugs
selcopintide
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT06264453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06264453.